Muscle-targeted gene therapy in glycogen storage disease type II with adeno-associated virus serotypes 7, 8, and 9

被引：0
|
作者：
Sun, Baodong [1 ]
Hauschka, Stephen [2 ]
Bird, Andrew [1 ]
Auten, Richard [3 ]
Koeberl, Divight [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27706 USA
[2] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
[3] Duke Univ, Med Ctr, Dept Pediat, Div Neonatol, Durham, NC 27706 USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2008年 / 93卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
95
引用
收藏
页码：S38 / S39
页数：2
相关论文
共 50 条
  • [1] Development of a hybrid adenovirus/adeno-associated virus vector for gene therapy in glycogen storage disease type II
    Koeberl, DD
    Sun, BD
    Andrew, B
    Amalfitano, A
    Chen, YT
    PEDIATRIC RESEARCH, 2003, 53 (04) : 259A - 260A
  • [2] Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II
    Sun, BD
    Zhang, HY
    Franco, LM
    Young, SP
    Schneider, A
    Bird, A
    Amalfitano, A
    Chen, YT
    Koeberl, DD
    MOLECULAR THERAPY, 2005, 11 (01) : 57 - 65
  • [3] Gene therapy with adeno-associated virus (AAV) vectors in canine glycogen storage disease, type Ia.
    Beaty, RM
    Jackson, M
    Kishnani, PS
    Faulkner, E
    VanCamp, S
    Brown, T
    Boney, A
    Chen, YT
    Koeberl, DD
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 432 - 432
  • [4] Correction of glycogen storage disease type II (GSD II) with an adeno-associated virus 8 (AAV2/8) vector
    Sun, BD
    Zhang, HY
    Franco, L
    Schneider, A
    Bird, A
    Amalfitano, A
    Chen, YT
    Koeberl, DD
    MOLECULAR THERAPY, 2004, 9 : S265 - S266
  • [5] Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter
    Sun, BD
    Zhang, HY
    Franco, LM
    Brown, T
    Bird, A
    Schneider, A
    Koeberl, DD
    MOLECULAR THERAPY, 2005, 11 (06) : 889 - 898
  • [6] Adeno-Associated Virus Gene Therapy Prevents Hepatocellular Adenoma in Murine Model of Glycogen Storage Disease Type Ia
    Wang, Lili
    HEPATOLOGY, 2012, 56 (05) : 1593 - 1595
  • [7] Gene replacement therapy for glycogen storage disease type II with recombinant adeno-associated virus serotype 1 (AAV1) vectors
    Fraites, TJ
    Germain, SA
    Cahill, KS
    Cloutier, DA
    Porvasnik, SL
    Zolotukhin, I
    Walter, GA
    Byrne, BJ
    CIRCULATION, 2002, 106 (19) : 127 - 127
  • [8] Mapping the Antigenic Structure of Adeno-Associated Virus Serotypes 8 and 9
    Tseng, Yu-Shan
    Van Vliet, Kim
    Kaplan, Matias
    Smith, J. Kennon
    Rao, Lavanya
    McKenna, Robert
    Byrne, Barry J.
    Zolotukhin, Sergei
    Asokan, Aravind
    Agbandje-McKenna, Mavis
    MOLECULAR THERAPY, 2014, 22 : S1 - S1
  • [9] Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia
    Koeberl, D. D.
    Sun, B. D.
    Damodaran, T. V.
    Brown, T.
    Millington, D. S.
    Benjamin, D. J., Jr.
    Bird, A.
    Schneider, A.
    Hillman, S.
    Jackson, M.
    Beaty, R. M.
    Chen, Y. T.
    GENE THERAPY, 2006, 13 (17) : 1281 - 1289
  • [10] Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia
    D D Koeberl
    B D Sun
    T V Damodaran
    T Brown
    D S Millington
    D K Benjamin
    A Bird
    A Schneider
    S Hillman
    M Jackson
    R M Beaty
    Y T Chen
    Gene Therapy, 2006, 13 : 1281 - 1289
12345